A clinical trial evaluating the detection of minimal residual disease (MRD) in patients with chronic myeloid leukemia by DNA-PCR
Not Applicable
- Conditions
- chronic myeloid leukemia
- Registration Number
- JPRN-UMIN000006489
- Lead Sponsor
- Juntendo University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 3
Inclusion Criteria
Not provided
Exclusion Criteria
Patients whose bone marrow cells or paraffin-embedded tissue prior to the treatment are not available
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Amount of BCR-ABL genomic DNA in peripheral blood collected during drug treatment (DNA-PCR method)
- Secondary Outcome Measures
Name Time Method